̽»¨Ö±²¥

Tammy Dougan on why it's so important that universities work with industry to get fundamental science out of the lab and into the real world.

Hear from four of our leading researchers on their work and why partnering with industry is key to their success.  

̽»¨Ö±²¥Maxwell Centre at the ̽»¨Ö±²¥ of Cambridge and , leaders in data and AI, are launching a partnership aimed at accelerating healthcare innovation through enhanced access to advanced analytics.

Industry placements for PhD students can be hugely beneficial for all concerned. We hear from two former students and the companies they worked for.

̽»¨Ö±²¥facility, based at the Milner Therapeutics Institute, will support the discovery of new medicines and diagnostics for chronic diseases by applying advanced biological and technological tools, including CRISPR gene editing.

Cambridge’s leadership in knowledge exchange has been recognised in the Knowledge Exchange Framework 2 (KEF2) results, published by Research England on 27 September 2022.

Three companies, Astex Pharmaceuticals, Eisai Ltd and Eli Lilly and Company, are joining forces with research scientists across Cambridge to explore promising new approaches to the treatment of neurodegenerative disease.

̽»¨Ö±²¥ ̽»¨Ö±²¥ of Cambridge has joined European partners in a major study of proteins which will shed light on the role played by biological systems in health and disease.

Two of Europe’s leading research universities have announced the first step towards plans for a unique ‘strategic partnership’ – underlining the vital and ongoing relationship between British universities and their peer institutions across the EU in a post-Brexit landscape.

Cambridge’s engagement with India has evolved from scholars working on India to scholars working with, and increasingly, in India – on shared priorities, to mutual advantage. Joya Chatterji, Toby Wilkinson and Bhaskar Vira explain why this is, as we begin a month-long focus on some of our India-related research.